30 related articles for article (PubMed ID: 10692218)
1. Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
Dowsett M; Ellis MJ; Dixon JM; Gluz O; Robertson J; Kates R; Suman VJ; Turnbull AK; Nitz U; Christgen M; Kreipe H; Kuemmel S; Bliss JM; Barry P; Johnston SR; Jacobs SA; Ma CX; Smith IE; Harbeck N
NPJ Breast Cancer; 2020; 6():21. PubMed ID: 32550266
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemistry using Liquid-based Cytology: A Tool in Hormone Receptor Analysis of Breast Cancer.
Tripathy K; Mishra A; Singh AK; Panda PL; Mahapatra A; Lenka A
J Cytol; 2018; 35(4):260-264. PubMed ID: 30498302
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma.
Toi PC; Neelaiah S; Dharanipragada K; Surendra K
J Cytol; 2018; 35(4):223-228. PubMed ID: 30498294
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Immunocytochemistry and Immunohistochemistry on Breast Carcinoma: A Boon or a Bane?
Geethamala K; Murthy VS; Vani BR; Rao MS; Thejaswini MU; Padmaja KP
J Lab Physicians; 2017; 9(1):5-10. PubMed ID: 28042209
[TBL] [Abstract][Full Text] [Related]
5. AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues.
Juan G; Bush TL; Ma C; Manoukian R; Chung G; Hawkins JM; Zoog S; Kendall R; Radinsky R; Loberg R; Friberg G; Payton M
J Transl Med; 2014 Nov; 12():307. PubMed ID: 25367255
[TBL] [Abstract][Full Text] [Related]
6. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.
Chen X; Sun L; Mao Y; Zhu S; Wu J; Huang O; Li Y; Chen W; Wang J; Yuan Y; Fei X; Jin X; Shen K
BMC Cancer; 2013 Aug; 13():390. PubMed ID: 23957561
[TBL] [Abstract][Full Text] [Related]
7. Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors.
Sauer T; Ebeltoft K; Pedersen MK; Kåresen R
Cytojournal; 2010 Dec; 7():24. PubMed ID: 21298022
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens.
Nishimura R; Aogi K; Yamamoto T; Takabatake D; Takashima S; Teramoto N; Kagawa A; Morita S
Virchows Arch; 2011 Feb; 458(2):153-8. PubMed ID: 21174117
[TBL] [Abstract][Full Text] [Related]
9. Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma.
Douglas-Jones AG; Collett N; Morgan JM; Jasani B
J Clin Pathol; 2001 Dec; 54(12):951-5. PubMed ID: 11729216
[TBL] [Abstract][Full Text] [Related]
10. Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring.
Ball HM; Hupp TR; Ziyaie D; Purdie CA; Kernohan NM; Thompson AM
Br J Cancer; 2001 Oct; 85(8):1102-5. PubMed ID: 11710820
[TBL] [Abstract][Full Text] [Related]
11. Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistry.
Zabaglo L; Ormerod MG; Dowsett M
Cytometry B Clin Cytom; 2003 Nov; 56(1):55-61. PubMed ID: 14582137
[TBL] [Abstract][Full Text] [Related]
12. What's new in steroid receptor immunocytochemistry in clinical oncology?
Ricketts D; Coombes RC
Pathol Res Pract; 1989 Dec; 185(6):935-41. PubMed ID: 2694124
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration techniques for the characterization of breast cancers.
Ljung BM; Chew K; Deng G; Matsumura K; Waldman F; Smith H
Cancer; 1994 Aug; 74(3 Suppl):1000-5. PubMed ID: 8039133
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.
Nizzoli R; Bozzetti C; Naldi N; Guazzi A; Gabrielli M; Michiara M; Camisa R; Barilli A; Cocconi G
Cancer; 2000 Feb; 90(1):61-6. PubMed ID: 10692218
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors.
Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G
Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211
[TBL] [Abstract][Full Text] [Related]
16. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
